Literature DB >> 28499012

Resistance to Alzheimer Disease Neuropathologic Changes and Apparent Cognitive Resilience in the Nun and Honolulu-Asia Aging Studies.

Caitlin S Latimer1, C Dirk Keene1, Margaret E Flanagan1, Laura S Hemmy1, Kelvin O Lim1, Lon R White1, Kathleen S Montine1, Thomas J Montine1.   

Abstract

Two population-based studies key to advancing knowledge of brain aging are the Honolulu-Asia Aging Study (HAAS) and the Nun Study. Harmonization of their neuropathologic data allows cross comparison, with findings common to both studies likely generalizable, while distinct observations may point to aging brain changes that are dependent on sex, ethnicity, environment, or lifestyle factors. Here, we expanded the neuropathologic evaluation of these 2 studies using revised NIA-Alzheimer's Association guidelines and compared directly the neuropathologic features of resistance and apparent cognitive resilience. There were significant differences in prevalence of Alzheimer disease neuropathologic change, small vessel vascular brain injury, and Lewy body disease between these 2 studies, suggesting that sex, ethnicity, and lifestyle factors may significantly influence resistance to developing brain injury with age. In contrast, hippocampal sclerosis prevalence was very similar, but skewed to poorer cognitive performance, suggesting that hippocampal sclerosis could act sequentially with other diseases to impair cognitive function. Strikingly, despite these observed differences, the proportion of individuals resistant to all 4 diseases of brain or displaying apparent cognitive resilience was virtually identical between HAAS and Nun Study participants. Future in vivo validation of these results awaits comprehensive biomarkers of these 4 brain diseases.
© 2017 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Alzheimer disease neuropathologic change; Cognitive resilience; NIA-AA guidelines; Population-based cohort

Mesh:

Substances:

Year:  2017        PMID: 28499012      PMCID: PMC6334750          DOI: 10.1093/jnen/nlx030

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.148


  52 in total

1.  Cerebrovascular pathology and dementia in autopsied Honolulu-Asia Aging Study participants.

Authors:  Lon White; Helen Petrovitch; John Hardman; James Nelson; Daron G Davis; G Webster Ross; Kamal Masaki; Lenore Launer; William R Markesbery
Journal:  Ann N Y Acad Sci       Date:  2002-11       Impact factor: 5.691

2.  A total score for the CERAD neuropsychological battery.

Authors:  M J Chandler; L H Lacritz; L S Hynan; H D Barnard; G Allen; M Deschner; M F Weiner; C M Cullum
Journal:  Neurology       Date:  2005-07-12       Impact factor: 9.910

3.  Sex differences in the clinical manifestations of Alzheimer disease pathology.

Authors:  Lisa L Barnes; Robert S Wilson; Julia L Bienias; Julie A Schneider; Denis A Evans; David A Bennett
Journal:  Arch Gen Psychiatry       Date:  2005-06

4.  Association of apolipoprotein E polymorphism in late-onset Alzheimer's disease and vascular dementia in Brazilians.

Authors:  D R S Souza; M R de Godoy; J Hotta; E H Tajara; A C Brandão; S Pinheiro Júnior; W A Tognola; J E dos Santos
Journal:  Braz J Med Biol Res       Date:  2003-06-26       Impact factor: 2.590

5.  Neuropathology of cognitively normal elderly.

Authors:  D S Knopman; J E Parisi; A Salviati; M Floriach-Robert; B F Boeve; R J Ivnik; G E Smith; D W Dickson; K A Johnson; L E Petersen; W C McDonald; H Braak; R C Petersen
Journal:  J Neuropathol Exp Neurol       Date:  2003-11       Impact factor: 3.685

6.  Apolipoprotein E epsilon4 genotype as a risk factor for cognitive decline and dementia: data from the Canadian Study of Health and Aging.

Authors:  Ging-Yuek R Hsiung; A Dessa Sadovnick; Howard Feldman
Journal:  CMAJ       Date:  2004-10-12       Impact factor: 8.262

7.  Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study.

Authors:  Robert D Abbott; G Webster Ross; Lon R White; Wayne T Sanderson; Cecil M Burchfiel; Michael Kashon; Dan S Sharp; Kamal H Masaki; J David Curb; Helen Petrovitch
Journal:  J Neurol       Date:  2003-10       Impact factor: 4.849

8.  Healthy aging and dementia: findings from the Nun Study.

Authors:  David A Snowdon
Journal:  Ann Intern Med       Date:  2003-09-02       Impact factor: 25.391

Review 9.  Neuropathological stageing of Alzheimer-related changes.

Authors:  H Braak; E Braak
Journal:  Acta Neuropathol       Date:  1991       Impact factor: 17.088

10.  Alzheimer's neurofibrillary pathology and the spectrum of cognitive function: findings from the Nun Study.

Authors:  Kathryn P Riley; David A Snowdon; William R Markesbery
Journal:  Ann Neurol       Date:  2002-05       Impact factor: 10.422

View more
  18 in total

1.  Increased Hyaluronan and TSG-6 in Association with Neuropathologic Changes of Alzheimer's Disease.

Authors:  May J Reed; Mamatha Damodarasamy; Jasmine L Pathan; Christina K Chan; Charles Spiekerman; Thomas N Wight; William A Banks; Anthony J Day; Robert B Vernon; C Dirk Keene
Journal:  J Alzheimers Dis       Date:  2019       Impact factor: 4.472

2.  Brain Injury and Later-Life Cognitive Impairment and Neuropathology: The Honolulu-Asia Aging Study.

Authors:  E Julia Chosy; Noele Gross; Marnie Meyer; Catherine Y Liu; Steven D Edland; Lenore J Launer; Lon R White
Journal:  J Alzheimers Dis       Date:  2020       Impact factor: 4.472

3.  Brain morphology, cognition, and β-amyloid in older adults with superior memory performance.

Authors:  Theresa M Harrison; Anne Maass; Suzanne L Baker; William J Jagust
Journal:  Neurobiol Aging       Date:  2018-03-27       Impact factor: 4.673

4.  Neuropathology Studies of Dementia in US Persons other than Non-Hispanic Whites.

Authors:  My-le Nguyen; Emily Z Huie; Rachel A Whitmer; Kristen M George; Brittany N Dugger
Journal:  Free Neuropathol       Date:  2022-03-10

5.  TDP-43 Neuropathologic Associations in the Nun Study and the Honolulu-Asia Aging Study.

Authors:  Margaret E Flanagan; Brenna Cholerton; Caitlin S Latimer; Laura S Hemmy; Steven D Edland; Kathleen S Montine; Lon R White; Thomas J Montine
Journal:  J Alzheimers Dis       Date:  2018       Impact factor: 4.472

Review 6.  Resistance vs resilience to Alzheimer disease: Clarifying terminology for preclinical studies.

Authors:  Eider M Arenaza-Urquijo; Prashanthi Vemuri
Journal:  Neurology       Date:  2018-03-28       Impact factor: 9.910

Review 7.  Microglia and modifiable life factors: Potential contributions to cognitive resilience in aging.

Authors:  Michael R Duggan; Vinay Parikh
Journal:  Behav Brain Res       Date:  2021-02-25       Impact factor: 3.332

Review 8.  Cognitive Impairment in Older Adults and Therapeutic Strategies.

Authors:  Thomas J Montine; Syed A Bukhari; Lon R White
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

Review 9.  Functional cognitive disorder: dementia's blind spot.

Authors:  Harriet A Ball; Laura McWhirter; Clive Ballard; Rohan Bhome; Daniel J Blackburn; Mark J Edwards; Stephen M Fleming; Nick C Fox; Robert Howard; Jonathan Huntley; Jeremy D Isaacs; Andrew J Larner; Timothy R Nicholson; Catherine M Pennington; Norman Poole; Gary Price; Jason P Price; Markus Reuber; Craig Ritchie; Martin N Rossor; Jonathan M Schott; Tiago Teodoro; Annalena Venneri; Jon Stone; Alan J Carson
Journal:  Brain       Date:  2020-10-01       Impact factor: 13.501

Review 10.  Dementia prevention, intervention, and care: 2020 report of the Lancet Commission.

Authors:  Gill Livingston; Jonathan Huntley; Andrew Sommerlad; David Ames; Clive Ballard; Sube Banerjee; Carol Brayne; Alistair Burns; Jiska Cohen-Mansfield; Claudia Cooper; Sergi G Costafreda; Amit Dias; Nick Fox; Laura N Gitlin; Robert Howard; Helen C Kales; Mika Kivimäki; Eric B Larson; Adesola Ogunniyi; Vasiliki Orgeta; Karen Ritchie; Kenneth Rockwood; Elizabeth L Sampson; Quincy Samus; Lon S Schneider; Geir Selbæk; Linda Teri; Naaheed Mukadam
Journal:  Lancet       Date:  2020-07-30       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.